Form D · Other Health Care
Bobo Labs Inc
Yardlsley, PA · CIK 0002055372
Offering snapshot reported Feb 11, 2025 · SEC filing
- Reported sold
- $250K Offering amount: $6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jan 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2025 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537851
Source: Form D, filed Feb 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Walid Abboud | Director |
| Lawrence Bell | Director |
| Barry Bruno | Director, Executive |
| Felipe Jimenez | Director |
| Edouard Fernand Le Marie | Director |
| Ludmilla Le Marie | Director |
| Benedicte Le Marie | Director |
| Michael Mc Namara | Director |
| Turner Novak | Director |
| Kethleen Widmer | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
913 N Pennsylvania Av
Yardlsley, PA, 10967
Yardlsley, PA, 10967